Somagenetix is  a new company that aims at becoming a leading gene therapy company with first-in-class treatment for phagocyte-related disorders.
We are spin-off from the University of Zurich and we are leveraging world-class scientific and clinical expertise to solve unmet medical needs through gene therapy. 
Carried by a highly experienced scientific team with over 17 years experience in gene therapy research, clinical development and applications, our mission  is to cure all patients with Phagocyte Disorders.
A cutting-edge technology with a complete & unique platform solving all challenges of ex-vivo gene therapies: specificity, long-term efficacy and safety.
Our goal is to cure patients with immunodeficiency, neurodegeneration and cancer with brain metastasis via genetically enhanced phagocytes.

Somagenetix

Org chart

Teams

Offices

Somagenetix

Org chart

Teams

Offices

Related companies